Showing results (201-210 of 389) with videos related to
Sort By:
Pageof 39
Cancer Science|May 20, 2014
Phase II study of zoledronic acid combined with docetaxel for non-small-cell lung cancer: West Japan Oncology GroupHaruyasu Murakami, Takeharu Yamanaka, Takashi Seto, et al.Thoracic Cancer|August 26, 2020
Association of Mps one binder kinase activator 1 (MOB1) expression with poor disease-free survival in individuals with non-small cell lung cancerNobuhisa Ando, Kentaro Tanaka, Kohei Otsubo, et al.Therapeutic Advances in Medical Oncology|January 20, 2026
Impact of vulnerability on concurrent chemoradiotherapy outcomes in patients with locally advanced non-small cell lung cancer using an integrated clinical trial databaseKenji Morimoto, Tadaaki Yamada, Naoya Nishioka, et al.Clinical Lung Cancer|February 15, 2024
Efficacy of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Non-Small Cell Lung Cancer Patients with Poor Performance Status and Epidermal Growth Factor Receptor Mutations: Findings from the Japanese Lung Cancer Registry DatabaseYusuke Okuma, Yasushi Shintani, Ikuo Sekine, et al.International Journal of Cancer|December 10, 2008
SRPX2 is overexpressed in gastric cancer and promotes cellular migration and adhesionKaoru Tanaka, Tokuzo Arao, Mari Maegawa, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 6, 2011
Association of the expression of mutant epidermal growth factor receptor protein as determined with mutation-specific antibodies in non-small cell lung cancer with progression-free survival after gefitinib treatmentKoichi Azuma, Isamu Okamoto, Akihiko Kawahara, et al.European Journal of Cancer (Oxford, England : 1990)|December 27, 2021
Trastuzumab emtansine for patients with non-small cell lung cancer positive for human epidermal growth factor receptor 2 exon-20 insertion mutationsEiji Iwama, Yoshitaka Zenke, Shunichi Sugawara, et al.Cancer Research|January 9, 2003
Constitutively active forms of c-Jun NH2-terminal kinase are expressed in primary glial tumorsHiromasa Tsuiki, Mehdi Tnani, Isamu Okamoto, et al.Cancer Science|February 28, 2020
A Japanese lung cancer registry study on demographics and treatment modalities in medically treated patientsIkuo Sekine, Yasushi Shintani, Takehito Shukuya, et al.Translational Lung Cancer Research|December 15, 2022
Association of thyroid transcription factor-1 (TTF-1) expression with efficacy of PD-1/PD-L1 inhibitors plus pemetrexed and platinum chemotherapy in advanced non-squamous non-small cell lung cancerRitsu Ibusuki, Yasuto Yoneshima, Mikiko Hashisako, et al.Pageof 39